Strategic Global Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,830
| Closed | -$2.19M | – | 146 |
|
|
2025
Q1 | $2.19M | Sell |
19,830
-691
| -3% | -$76.4K | 0.43% | 68 |
|
|
2024
Q4 | $2.8M | Buy |
20,521
+827
| +4% | +$113K | 0.51% | 57 |
|
|
2024
Q3 | $2.27M | Sell |
19,694
-188
| -0.9% | -$21.7K | 0.45% | 66 |
|
|
2024
Q2 | $2.74M | Buy |
19,882
+12,318
| +163% | +$1.7M | 0.57% | 57 |
|
|
2024
Q1 | $1.04M | Buy |
+7,564
| New | +$1.04M | 0.23% | 101 |
|